Skip to main content

Rectal versus vaginal bromocriptine mesylate suppositories in hyperprolactinemic patients : an active comparator trial .

Research Abstract
The approached bromocriptine suppositories containing pluronic F127 were proven to be effective in lowering SP whether used vaginally or rectally as compared to oral treatment. Rectal approach has minimal side effects, it is more convenient for patients who don’t accept to manipulate the vagina especially virgins, others fail to use the drug during menstruation, or during the postabortive or postpartum periods and those patients who believe that the drug may affect their fertility by interfering with sexual relationship. Furthermore, it can be used by intolerant hyperprolactinemic males. Its use as an alternative non-oral approach should be considered during counseling of patients in those formerly mentioned situations.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El-Gebali, Sahar B. Hassan, Mohammad E. Ali
Research Journal
Middle East Fertility Society Journal
Research Rank
1
Research Vol
12,2:
Research Year
2007

Rectal versus vaginal bromocriptine mesylate suppositories in hyperprolactinemic patients : an active comparator trial .

Research Abstract
The approached bromocriptine suppositories containing pluronic F127 were proven to be effective in lowering SP whether used vaginally or rectally as compared to oral treatment. Rectal approach has minimal side effects, it is more convenient for patients who don’t accept to manipulate the vagina especially virgins, others fail to use the drug during menstruation, or during the postabortive or postpartum periods and those patients who believe that the drug may affect their fertility by interfering with sexual relationship. Furthermore, it can be used by intolerant hyperprolactinemic males. Its use as an alternative non-oral approach should be considered during counseling of patients in those formerly mentioned situations.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El-Gebali, Sahar B. Hassan, Mohammad E. Ali
Research Journal
Middle East Fertility Society Journal
Research Rank
1
Research Vol
12,2:
Research Year
2007

Rectal versus vaginal bromocriptine mesylate suppositories in hyperprolactinemic patients : an active comparator trial .

Research Abstract
The approached bromocriptine suppositories containing pluronic F127 were proven to be effective in lowering SP whether used vaginally or rectally as compared to oral treatment. Rectal approach has minimal side effects, it is more convenient for patients who don’t accept to manipulate the vagina especially virgins, others fail to use the drug during menstruation, or during the postabortive or postpartum periods and those patients who believe that the drug may affect their fertility by interfering with sexual relationship. Furthermore, it can be used by intolerant hyperprolactinemic males. Its use as an alternative non-oral approach should be considered during counseling of patients in those formerly mentioned situations.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El-Gebali, Sahar B. Hassan, Mohammad E. Ali
Research Department
Research Journal
Middle East Fertility Society Journal
Research Member
Ibrahim Elsayed El-Gibaly Khudair
Research Rank
1
Research Vol
12,2:
Research Year
2007

Rectal versus vaginal bromocriptine mesylate suppositories in hyperprolactinemic patients : an active comparator trial .

Research Abstract
The approached bromocriptine suppositories containing pluronic F127 were proven to be effective in lowering SP whether used vaginally or rectally as compared to oral treatment. Rectal approach has minimal side effects, it is more convenient for patients who don’t accept to manipulate the vagina especially virgins, others fail to use the drug during menstruation, or during the postabortive or postpartum periods and those patients who believe that the drug may affect their fertility by interfering with sexual relationship. Furthermore, it can be used by intolerant hyperprolactinemic males. Its use as an alternative non-oral approach should be considered during counseling of patients in those formerly mentioned situations.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El-Gebali, Sahar B. Hassan, Mohammad E. Ali
Research Department
Research Journal
Middle East Fertility Society Journal
Research Rank
1
Research Vol
12,2:
Research Year
2007

Evaluation of a Novel Vaginal Bromocriptine Mesylate Formulation: A Pilot Study.

Research Abstract
Because of the frequent side effects found with oral bromocriptine, we created two formulas of vaginal bromocriptine suppositories to compare with vaginal application of bromocriptine tablets. The formula containing bromocriptine and a releasing agent (Pluronic F127) showed an increased dissolution rate, 39-fold greater than that of the pure drug alone, and subsequently was effective in lowering serum prolactin.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El- Gebali, Sahar B. Hassan.,
Research Department
Research Journal
Fertility and Sterility
Research Member
Research Rank
1
Research Vol
83 (4),
Research Website
http://www.researchgate.net/publication/7915608_Evaluation_of_a_novel_vaginal_bromocriptine_mesylate_formulation_a_pilot_study
Research Year
2005
Subscribe to